Albert Font
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- Prostate Cancer Treatment and Research 31
- Lung Cancer Treatments and Mutations 10
- Oncology 30
- Cancer Treatment and Pharmacology 8
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Vicenç Ruiz de Porras (14 shared papers)Rafael Rosell (9 shared papers)Johann S. de Bono (5 shared papers)Albert Abad (4 shared papers)Mariano Monzó (4 shared papers)Rafael Rosell (6 shared papers)Àlex Pifarré (4 shared papers)Joan Carles (9 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Annals of Oncology (10 papers)International Journal of Molecular Sciences (3 papers)Cancers (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Albert Font
72 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 79
- Pulmonary and Respiratory Medicine 755
- Cancer Research 303
- Oncology 527
- Internal Medicine 45
- Pathology and Forensic Medicine 157
Countries citing papers authored by Albert Font
This map shows the geographic impact of Albert Font's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Font with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Font more than expected).
Fields of papers citing papers by Albert Font
This network shows the impact of papers produced by Albert Font. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Font. The network helps show where Albert Font may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert Font, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 229 | |
| 2 | 2017 | 169 | |
| 3 | 2014 | 124 | |
| 4 | 1998 | 112 | |
| 5 | 2010 | 107 | |
| 6 | 2013 | 54 | |
| 7 | 2001 | 54 | |
| 8 | 2014 | 49 | |
| 9 | 2020 | 48 | |
| 10 | 2003 | 48 | |
| 11 | 2021 | 46 | |
| 12 | 2016 | 40 | |
| 13 | 2009 | 39 | |
| 14 | 2020 | 35 | |
| 15 | 2022 | 35 | |
| 16 | 2020 | 34 | |
| 17 | 2022 | 33 | |
| 18 | 2004 | 32 | |
| 19 | 1996 | 27 | |
| 20 | 2016 | 26 |
About Albert Font
Albert Font is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Cancer Research, having authored 75 papers that have together received 1.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (31 papers), Bladder and Urothelial Cancer Treatments (12 papers), Lung Cancer Treatments and Mutations (10 papers), Cancer, Lipids, and Metabolism (9 papers), Cancer Treatment and Pharmacology (8 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Urinary and Genital Oncology Studies (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (755 citations), Cancer Research (303 citations), Oncology (527 citations), Internal Medicine (45 citations) and Pathology and Forensic Medicine (157 citations). Albert Font has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Vicenç Ruiz de Porras, Rafael Rosell, Johann S. de Bono, Albert Abad, Mariano Monzó, Rafael Rosell, Àlex Pifarré, Joan Carles, Isabel Ojanguren and Christophe Massard. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, International Journal of Molecular Sciences, Cancers and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.